An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade
Lynda Vuong(Memorial Sloan Kettering Cancer Center), Alison C. MacKinnon(Galecto (Denmark))
Cited by 140
Related Papers
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
|Nature Medicine|1999|740
Regulation of Alternative Macrophage Activation by Galectin-3
|The Journal of Immunology|2008|29